RNA Disease Diagnostics Appoints John W. Erickson, Jr. President

RNA Disease Diagnostics, Inc., a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced today the appointment of John W. Erickson, Jr. to the newly created position of President.

John W. Erickson will lead day-to-day operations, reporting directly to RNA Disease Diagnostics co-founder and Executive Chairman, Allan Oberman.

In an executive management career spanning more than three decades, Mr. Erickson has worked with healthcare, life science, and clinical diagnostics businesses ranging from venture capital-backed start-ups to Fortune 50 companies, building out global commercial capabilities, leading marketing and sales teams, delivering operational excellence and profitable growth, while cultivating strong thought leader relationships across multiple specialties.

Erickson joins RNA Disease Diagnosticsfrom his management and strategy consulting firm, Erickson Healthcare Consulting, which he founded in 2017. Previously, he held C-suite and senior executive leadership positions with RapidBio Systems, Johnson & Johnson (LifeScan), Abbott Laboratories, ITC-Nexus Dx, and Bio-Rad Laboratories. Notably, in those roles, Mr. Erickson played a key role in the development and commercialization of over 36 products, which have generated cumulative sales in excess of $4 billion. Mr. Erickson holds a Master of Science Degree in Management, Bachelor of Science degrees in both Chemistry and Biology, and has completed graduate studies in Biochemistry, Toxicology and Endocrinology.

“I am very pleased to have recruited an executive of John’s caliber to this key position,” said Mr. Oberman. “His extensive and demonstrable record of accomplishment in helping to commercialize new diagnostics technologies in particular will be a great asset for RNA Disease Diagnostics going forward. John is exceptionally qualified to help us maximize the development and commercialization of our Antisense RNA diagnostic platform across multiple diseases.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy